Colonial Trust Advisors Dexcom Inc Transaction History

Colonial Trust Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$114.22 - $140.1 $799 - $980	-7 Reduced 35.0%	13 $1,000
Q4 2023 Feb 14, 2024	SELL	$75.49 - $124.16 $679 - $1,117	-9 Reduced 31.03%	20 $2,000
Q1 2023 May 11, 2023	BUY	$104.0 - $122.92 $312 - $368	3 Added 11.54%	29 $3,000
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $2,209 - $3,189	26 New	26 $2,000

1,016

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.2B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Colonial Trust Advisors, based on Form 13F filings with the SEC.

Stay updated on Colonial Trust Advisors with notifications on news.